A5042344208- Organ Donation and Transplantation
- Renal Transplantation Outcomes and Treatments
- Organ Transplantation Techniques and Outcomes
- Renal and Vascular Pathologies
- Grief, Bereavement, and Mental Health
- Neurological Complications and Syndromes
- Transplantation: Methods and Outcomes
- Hospital Admissions and Outcomes
- Dialysis and Renal Disease Management
- Tumors and Oncological Cases
- Antifungal resistance and susceptibility
- Organ and Tissue Transplantation Research
- Plant Pathogens and Fungal Diseases
- Innovations in Medical Education
- Renal and related cancers
- Polyomavirus and related diseases
- Liver Disease and Transplantation
- Biomedical Research and Pathophysiology
- Bone and Joint Diseases
- Social Media in Health Education
- Biosimilars and Bioanalytical Methods
- Fungal Infections and Studies
- Renal Diseases and Glomerulopathies
- Complement system in diseases
- Erythropoietin and Anemia Treatment
University of Virginia
2016-2024
University of Virginia Health System
2013-2024
University of Virginia Medical Center
2020
Kidney transplant is not only the best treatment for patients with advanced kidney disease but it also reduces health care expenditure. The management of complex as they require special by nephrologists who have expertise in assessing candidates, understand immunology and organ rejection, familiarity perioperative complications, ability to manage long-term effects chronic immunosuppression. This skill set at intersection multiple disciplines necessitates additional training Transplant...
Among adults, living donor kidney transplant rates began declining in the United States after 2004 but whether a similar decline is occurring pediatric candidates has not been well studied. Share 35, change allocation rules implemented October of 2005, may also have influenced donation. We sought to determine was and 35 program cause decline. All children listed for or transplanted with without listing between 1996 2011 were identified (N=14 911) which 6046 had received during follow-up....
Background Previous analyses of the United States transplant database regarding long-term outcomes in kidney transplantation have shown minimal improvement rate graft loss. This study sought to analyze intermediate-term and function at 6 months adult living deceased donor recipients last decade. Methods Survival analysis was performed based on year between 3 years’ posttransplant. The Chronic Kidney Disease Epidemiology Collaboration estimated glomerular filtration (eGFR) determined months....
Abstract Kidney transplantation is the most successful kidney replacement therapy available, resulting in improved recipient survival and societal cost savings. Yet, nearly 70 years after first transplant, there are still numerous barriers untapped opportunities that constrain access to transplant. The literature describing these extensive, but practices processes solve them less clear. Solutions must be multidisciplinary product of strong partnerships among patients, their networks, health...
The evaluation and care of non-US citizen, residents who wish to come the United States serve as international living kidney donors (ILKDs) can pose unique challenges. We surveyed US transplant programs better understand practices related ILKD care. distributed survey by email professional society list-servs (Fall 2018, assessing 2017 experience). Eighty-five responded (36.8% program response rate), which 80 considered candidates. Only 18 had written protocols for evaluation. Programs a...
Abstract Background Five organs (heart, right lung, liver, right, and left kidneys) from a deceased patient were transplanted into five recipients in four US states; the was identified as part of healthcare‐associated fungal meningitis outbreak among patients who underwent epidural anesthesia Matamoros, Mexico. Methods After transplant surgeries occurred, Fusarium solani species complex, pathogen with high case‐mortality rate, cerebrospinal fluid organ donor by metagenomic next‐generation...
Kidney transplantation (KT) remains the treatment of choice for end-stage kidney disease (ESKD), but access to is limited by a disparity between supply and demand suitable organs. This organ shortfall has resulted in use wider range donor kidneys and, parallel, reexamination potential alternative renal replacement therapies. Previous studies comparing Canadian intensive home hemodialysis (IHHD) with deceased (DD) KT United States reported similar survival, suggesting IHHD might be plausible...
Journal of the American Society Nephrology 34(11S):p 608, November 2023. | DOI: 10.1681/ASN.20233411S1608a
Poster: Transplantation: Clinical - Underrecognized Risk Factors, Traditional Considerations, and Outcomes